News | April 02, 2015

Blood Test Can Help Identify Stroke Risk Following Heart Surgery

Elevated blood urea nitrogen could indicate poor kidney function, possible precursor for stroke

blood urea nitrogen, BUN, postoperative stroke, risk, test, Wake Forest Baptist

April 2, 2015 — The results of a blood test done immediately after heart surgery can be a meaningful indicator of postoperative stroke risk, a study by researchers at Wake Forest Baptist Medical Center has found.

An acutely elevated level of blood urea nitrogen (BUN) — a measure of kidney function detected through blood testing — was the most powerful predictor of postoperative stroke among the study’s subjects.

Up to 9 percent of cardiac surgery patients suffer post-operative stroke, and these events are significantly more serious and more frequently fatal than those experienced in the general population.

“An elevated BUN level after surgery tells us that the kidneys aren’t working well, which could mean that the blood vessels feeding the kidneys may be narrow,” said Martinson K. Arnan, assistant professor of neurology at Wake Forest Baptist and lead author of the study, which was published in the March online issue of the Annals of Thoracic Surgery. “We found that if kidney vessels aren’t performing well, it is likely that other vessels in the body, including the brain, aren’t working well either, resulting in a higher risk of stroke.”

In the case-controlled study, the researchers analyzed 5,498 adults 18 to 90 years old who underwent cardiac surgery from 2005 to 2010 and identified 180 who suffered a stroke within 10 days of surgery. An elevated BUN level was not only the most accurate predictor of stroke in this group, it greatly exceeded the predictive accuracy of more commonly recognized risk factors such as smoking, pre-operative high blood pressure and emergency surgery.

The test that measures BUN is inexpensive and routinely administered before and after all cardiac surgeries. However, the test is most effective as a predictor for stroke if it is administered immediately after surgery rather than at the discretion of the physician, which is the current practice, Arnan said.

“Based on our research, we need to more carefully monitor patients with high BUN postoperatively for any symptoms of stroke so that they may benefit from therapy immediately,” he said. “Anything that can help us better assess that risk can help decrease the incidence of stroke, decrease disability and reduce expenses.”

This research also suggests that there may be a role for evaluating the narrowness of blood vessels bringing blood to the kidneys prior to surgery as a means of decreasing stroke risk.
For more information: www.wakehealth.edu

Related Content

Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Overlay Init